Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_status_consensus
TRAIP	10293	broad.mit.edu	37	3	49881134	49881134	+	Intron	SNP	A	A	T	rs2246832	by1000genomes	THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	g.chr3:49881134A>T	ENST00000331456.2	-	5	522				TRAIP_ENST00000473863.1_5'Flank|TRAIP_ENST00000469027.1_Intron	NM_005879.2	NP_005870.2	Q9BWF2	TRAIP_HUMAN	TRAF interacting protein	NA		NA		NA	cell proliferation|induction of apoptosis	perinuclear region of cytoplasm	protein binding|zinc ion binding			breast(1)|endometrium(3)|kidney(2)|large_intestine(2)|liver(2)|lung(9)|ovary(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)	24				BRCA - Breast invasive adenocarcinoma(193;4.71e-05)|KIRC - Kidney renal clear cell carcinoma(197;0.00558)|Kidney(197;0.00632)		AACCAAGGTGATGACTGGAGC	0.478		NA				NA		NA		NA	NA	NA	T	885	0.41	0.64	0.34	2184	0.17	1	,	,	NA	2e-04	0.46	NA	NA	0.4063	0.9999	LOWCOV	NA	NA	4e-04	SNP		NA			NA	NA		NA				0													NA	NA	NA	NA		NA	NA	NA		NA											NA				NA		NA	NA	NA	SO:0001627	intron_variant			ENSG00000183763	HGNC:30764	NM_005879	Approved	uc003cxs.1	NA	O00467	ENST00000331456.2	37	CCDS2806.1																																																																																			TRAIP-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000350518.1	-4.24588	KEEP	NA	-	8.24365	0.063492	4	59	---	---	---	---	1	0.036371	4	0	2	79	4	59	2	79	2	TP
HEXB	3074	broad.mit.edu	37	5	74001087	74001087	+	Missense_Mutation	SNP	T	T	C			THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	g.chr5:74001087T>C	ENST00000511181.1	+	6	950	c.38T>C	c.(37-39)aTa>aCa	p.I13T	HEXB_ENST00000261416.7_Missense_Mutation_p.I238T			P07686	HEXB_HUMAN	hexosaminidase B (beta polypeptide)	238		NA		NA	cell death	lysosome	cation binding|protein heterodimerization activity|protein homodimerization activity	p.I238K(1)		endometrium(2)|kidney(3)|large_intestine(4)|ovary(1)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	14		all_lung(232;0.00101)|Lung NSC(167;0.00278)|Ovarian(174;0.0129)|Breast(144;0.231)		OV - Ovarian serous cystadenocarcinoma(47;1.72e-57)		CACTGGCACATAGTTGATGAC	0.328		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(66;841 1270 13391 18706 27225)	NA			NA	NA		NA				1	Substitution - Missense(1)	kidney(1)											149	143	145	NA		NA	NA	5		NA											NA				74001087		2203	4300	6503	SO:0001583	missense			ENSG00000049860	HGNC:4879	NM_000521	Approved	uc003kdf.4	NA		ENST00000511181.1	37		.	.	.	.	.	.	.	.	.	.	T	19.78	3.891870	0.72524	.	.	ENSG00000049860	ENST00000511181;ENST00000261416	D;D	0.96265	-3.96;-3.96	5.81	5.81	0.92471	Glycoside hydrolase, subgroup, catalytic domain (1);Glycoside hydrolase, superfamily (1);Glycoside hydrolase, family 20, catalytic core (1);Glycoside hydrolase, family 20 (1);	0.040834	0.85682	D	0.000000	D	0.98924	0.9635	H	0.97806	4.08	0.80722	D	1	D	0.71674	0.998	D	0.91635	0.999	D	0.99482	1.0948	10	0.87932	D	0	-12.6011	16.1708	0.81812	0.0:0.0:0.0:1.0	.	238	P07686	HEXB_HUMAN	T	13;238	ENSP00000426285:I13T;ENSP00000261416:I238T	ENSP00000261416:I238T	I	+	2	0	HEXB	74036843	1.000000	0.71417	0.960000	0.40013	0.400000	0.30750	7.621000	0.83083	2.225000	0.72522	0.533000	0.62120	ATA	HEXB-002	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000369003.1	40.500467	KEEP	NA	+	40.500467	0.5	12	12	---	---	---	---	1	1	217	374	0	49	15	13	0	49	2	TP
EGFL8	80864	broad.mit.edu	37	6	32135007	32135007	+	Missense_Mutation	SNP	A	A	G			THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	g.chr6:32135007A>G	ENST00000395512.1	+	6	679	c.574A>G	c.(574-576)Acc>Gcc	p.T192A	PPT2-EGFL8_ENST00000422437.1_3'UTR|EGFL8_ENST00000333845.6_Missense_Mutation_p.T192A|AGPAT1_ENST00000490711.1_5'Flank			Q99944	EGFL8_HUMAN	EGF-like-domain, multiple 8	192		NA		NA		extracellular region|integral to membrane	calcium ion binding			cervix(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(1)|lung(4)|urinary_tract(1)	10						AGAGCCCCCAACCAGTGCCAG	0.662		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0													27	33	31	NA		NA	NA	6		NA											NA				32135007		1506	2706	4212	SO:0001583	missense			ENSG00000241404	HGNC:13944	NM_030652	Approved		NA	B0S884|Q5JP23|Q5SSX3|Q8IV30	ENST00000395512.1	37	CCDS4743.1	.	.	.	.	.	.	.	.	.	.	A	5.454	0.268826	0.10349	.	.	ENSG00000241404	ENST00000333845;ENST00000395512;ENST00000432129	D;D;T	0.88818	-2.43;-2.43;2.13	5.88	0.804	0.18697	.	.	.	.	.	T	0.65291	0.2677	L	0.57536	1.79	0.09310	N	1	B	0.24483	0.104	B	0.22386	0.039	T	0.52275	-0.8597	9	0.07325	T	0.83	-4.2978	2.2222	0.03975	0.4337:0.3335:0.0878:0.1449	.	192	Q99944	EGFL8_HUMAN	A	192;192;172	ENSP00000333380:T192A;ENSP00000378888:T192A;ENSP00000401694:T172A	ENSP00000333380:T192A	T	+	1	0	EGFL8	32242985	0.002000	0.14202	0.031000	0.17742	0.176000	0.22953	0.713000	0.25794	0.470000	0.27294	0.482000	0.46254	ACC	EGFL8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000076463.3	43.201756	KEEP	NA	+	45.925098	0.267857	15	41	---	---	---	---	1	0.9920237	13	12	0	72	16	42	0	72	2	TP
BRAF	673	broad.mit.edu	37	7	140453136	140453136	+	Missense_Mutation	SNP	A	A	T	rs121913377|rs121913227		THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	g.chr7:140453136A>T	ENST00000288602.6	-	15	1859	c.1799T>A	c.(1798-1800)gTg>gAg	p.V600E		NM_004333.4	NP_004324.2	P15056	BRAF_HUMAN	v-raf murine sarcoma viral oncogene homolog B	600	Protein kinase.	NA	V -> D (in a melanoma cell line; requires 2 nucleotide substitutions).|V -> E (in sarcoma, colorectal adenocarcinoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis).	NA	activation of MAPKK activity|anti-apoptosis|nerve growth factor receptor signaling pathway|organ morphogenesis|positive regulation of peptidyl-serine phosphorylation|small GTPase mediated signal transduction|synaptic transmission	cytosol|nucleus|plasma membrane	ATP binding|metal ion binding	p.V600E(15453)|p.V600K(252)|p.V600R(44)|p.V600D(16)|p.V600A(12)|p.V600_K601>E(12)|p.V600G(11)|p.T599_R603>I(2)|p.V600Q(2)|p.V600_S605>EK(1)|p.V600_S605>DV(1)|p.V600_S605>D(1)|p.T599_V600insDFGLAT(1)	SLC45A3/BRAF(2)|AGTRAP/BRAF(2)|FAM131B_ENST00000443739/BRAF(7)|AKAP9_ENST00000356239/BRAF(10)|KIAA1549/BRAF(703)|FCHSD1/BRAF(2)	NS(588)|adrenal_gland(3)|autonomic_ganglia(3)|biliary_tract(29)|bone(7)|breast(21)|central_nervous_system(99)|cervix(6)|endometrium(33)|eye(72)|gastrointestinal_tract_(site_indeterminate)(2)|genital_tract(4)|haematopoietic_and_lymphoid_tissue(436)|kidney(3)|large_intestine(6953)|liver(17)|lung(192)|oesophagus(4)|ovary(275)|pancreas(15)|pituitary(1)|prostate(25)|salivary_gland(1)|skin(6285)|small_intestine(12)|soft_tissue(40)|stomach(11)|testis(7)|thyroid(12220)|upper_aerodigestive_tract(13)|urinary_tract(3)	27380	Melanoma(164;0.00956)				Sorafenib(DB00398)	TCGAGATTTCACTGTAGCTAG	0.368	V600D(K029AX_SKIN)|V600D(WM115_SKIN)|V600D(WM2664_SKIN)|V600E(8505C_THYROID)|V600E(A101D_SKIN)|V600E(A2058_SKIN)|V600E(A375_SKIN)|V600E(A673_BONE)|V600E(AM38_CENTRAL_NERVOUS_SYSTEM)|V600E(BCPAP_THYROID)|V600E(BHT101_THYROID)|V600E(BT474_BREAST)|V600E(C32_SKIN)|V600E(CL34_LARGE_INTESTINE)|V600E(COLO205_LARGE_INTESTINE)|V600E(COLO679_SKIN)|V600E(COLO741_SKIN)|V600E(COLO783_SKIN)|V600E(COLO800_SKIN)|V600E(COLO818_SKIN)|V600E(COLO829_SKIN)|V600E(COLO849_SKIN)|V600E(DBTRG05MG_CENTRAL_NERVOUS_SYSTEM)|V600E(DU4475_BREAST)|V600E(ES2_OVARY)|V600E(G361_SKIN)|V600E(GCT_SOFT_TISSUE)|V600E(HS294T_SKIN)|V600E(HS695T_SKIN)|V600E(HS939T_SKIN)|V600E(IGR1_SKIN)|V600E(IGR37_SKIN)|V600E(IGR39_SKIN)|V600E(K029AX_SKIN)|V600E(KG1C_CENTRAL_NERVOUS_SYSTEM)|V600E(LOXIMVI_SKIN)|V600E(MALME3M_SKIN)|V600E(MELHO_SKIN)|V600E(OUMS23_LARGE_INTESTINE)|V600E(RKO_LARGE_INTESTINE)|V600E(RPMI7951_SKIN)|V600E(RVH421_SKIN)|V600E(SH4_SKIN)|V600E(SIGM5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|V600E(SKHEP1_LIVER)|V600E(SKMEL24_SKIN)|V600E(SKMEL28_SKIN)|V600E(SKMEL5_SKIN)|V600E(SW1417_LARGE_INTESTINE)|V600E(UACC257_SKIN)|V600E(UACC62_SKIN)|V600E(WM793_SKIN)|V600E(WM88_SKIN)|V600E(WM983B_SKIN)	61	"""Mis, T, O"""	"""AKAP9, KIAA1549"""	"""melanoma, colorectal, papillary thyroid, borderline ov, Non small-cell lung cancer (NSCLC), cholangiocarcinoma, pilocytic astrocytoma"""	NA	Cardio-facio-cutaneous syndrome	NA	Cardiofaciocutaneous syndrome	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(40;35 892 2973 5743 27438)	NA	Dom	yes	NA	7	7q34	673	v-raf murine sarcoma viral oncogene homolog B1	yes	E	15808	Substitution - Missense(15790)|Complex - deletion inframe(17)|Insertion - In frame(1)	thyroid(7476)|skin(3822)|large_intestine(3288)|NS(360)|haematopoietic_and_lymphoid_tissue(336)|ovary(211)|lung(58)|eye(57)|central_nervous_system(53)|soft_tissue(30)|biliary_tract(18)|liver(17)|prostate(13)|breast(10)|upper_aerodigestive_tract(9)|endometrium(8)|pancreas(8)|testis(7)|small_intestine(7)|genital_tract(4)|stomach(4)|bone(3)|autonomic_ganglia(2)|oesophagus(2)|urinary_tract(2)|adrenal_gland(2)|pituitary(1)											112	104	107	NA		NA	NA	7		NA											NA				140453136		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	CFC, CFCS	ENSG00000157764	HGNC:1097	NM_004333	Approved	uc003vwc.4	NA	A4D1T4|B6HY61|B6HY62|B6HY63|B6HY64|B6HY65|B6HY66|Q13878|Q3MIN6|Q9UDP8|Q9Y6T3	ENST00000288602.6	37	CCDS5863.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	24.0|24.0	4.486113|4.486113	0.84854|0.84854	.|.	.|.	ENSG00000157764|ENSG00000157764	ENST00000288602|ENST00000496384	D|.	0.81739|.	-1.53|.	5.65|5.65	5.65|5.65	0.86999|0.86999	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|.	0.61565|.	0.2357|.	L|L	0.42245|0.42245	1.32|1.32	0.80722|0.80722	D|D	1|1	D|.	0.55385|.	0.971|.	D|.	0.66351|.	0.943|.	T|.	0.58160|.	-0.7685|.	10|.	0.87932|.	D|.	0|.	.|.	15.9326|15.9326	0.79675|0.79675	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	600|.	P15056|.	BRAF_HUMAN|.	E|R	600|208	ENSP00000288602:V600E|.	ENSP00000288602:V600E|.	V|X	-|-	2|1	0|0	BRAF|BRAF	140099605|140099605	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	9.197000|9.197000	0.94985|0.94985	2.169000|2.169000	0.68431|0.68431	0.529000|0.529000	0.55759|0.55759	GTG|TGA	BRAF-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348886.1	38.625893	KEEP	NA	-	41.45968	0.259259	14	40	---	---	---	---	1	0.9495467	6	10	0	84	17	44	0	84	2	TP
DRD4	1815	broad.mit.edu	37	11	639803	639803	+	Missense_Mutation	SNP	G	G	T			THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	g.chr11:639803G>T	ENST00000176183.5	+	3	566	c.554G>T	c.(553-555)tGc>tTc	p.C185F		NM_000797.3	NP_000788.2	P21917	DRD4_HUMAN	dopamine receptor D4	185		NA		NA	activation of MAPK activity|adult locomotory behavior|arachidonic acid secretion|behavioral fear response|behavioral response to cocaine|behavioral response to ethanol|inhibition of adenylate cyclase activity by dopamine receptor signaling pathway|negative regulation of calcium ion transport via voltage-gated calcium channel activity|negative regulation of cAMP biosynthetic process|negative regulation of protein secretion|positive regulation of sodium:hydrogen antiporter activity|regulation of dopamine metabolic process|regulation of inhibitory postsynaptic membrane potential|response to amphetamine|response to histamine|social behavior	integral to plasma membrane	dopamine D4 receptor activity|drug binding|potassium channel regulator activity|SH3 domain binding			NS(1)|lung(1)|skin(1)|upper_aerodigestive_tract(1)	4		all_cancers(49;1.69e-08)|all_epithelial(84;1.65e-05)|Breast(177;0.000231)|Ovarian(85;0.000953)|Medulloblastoma(188;0.0109)|all_neural(188;0.0299)|Lung NSC(207;0.106)|all_lung(207;0.136)		all cancers(45;4.36e-28)|Epithelial(43;2.59e-27)|OV - Ovarian serous cystadenocarcinoma(40;3.53e-21)|BRCA - Breast invasive adenocarcinoma(625;4.23e-05)|Lung(200;0.0234)|LUSC - Lung squamous cell carcinoma(625;0.0703)	Apomorphine(DB00714)|Clozapine(DB00363)|Olanzapine(DB00334)|Pramipexole(DB00413)|Promazine(DB00420)|Propiomazine(DB00777)|Ropinirole(DB00268)|Thiethylperazine(DB00372)|Ziprasidone(DB00246)	CCCGCCGTGTGCCGCCTGGAG	0.711		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0													43	32	36	NA		NA	NA	11		NA											NA				639803		2197	4297	6494	SO:0001583	missense			ENSG00000069696	HGNC:3025	NM_000797	Approved	uc001lqp.2	NA	B0M0J7|Q7Z7Q5|Q8NGM5	ENST00000176183.5	37	CCDS7710.1	.	.	.	.	.	.	.	.	.	.	G	13.95	2.391083	0.42410	.	.	ENSG00000069696	ENST00000176183	T	0.62639	0.01	3.17	3.17	0.36434	GPCR, rhodopsin-like superfamily (1);	0.058704	0.64402	D	0.000001	T	0.77170	0.4091	.	.	.	0.80722	D	1	D	0.69078	0.997	D	0.70487	0.969	T	0.81504	-0.0903	9	0.87932	D	0	.	13.588	0.61942	0.0:0.0:1.0:0.0	.	185	P21917	DRD4_HUMAN	F	185	ENSP00000176183:C185F	ENSP00000176183:C185F	C	+	2	0	DRD4	629803	1.000000	0.71417	0.961000	0.40146	0.126000	0.20510	6.680000	0.74518	1.780000	0.52325	0.462000	0.41574	TGC	DRD4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000257109.1	28.410518	KEEP	NA	+	29.485732	0.314286	11	24	---	---	---	---	1	0.2959831	2	1	0	54	14	26	0	54	2	TP
KDM2A	22992	broad.mit.edu	37	11	67017761	67017761	+	Missense_Mutation	SNP	G	G	A			THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	g.chr11:67017761G>A	ENST00000529006.2	+	17	2706	c.2260G>A	c.(2260-2262)Gat>Aat	p.D754N	KDM2A_ENST00000530342.1_Missense_Mutation_p.D315N|KDM2A_ENST00000526258.1_3'UTR|KDM2A_ENST00000398645.2_Missense_Mutation_p.D754N|KDM2A_ENST00000308783.5_Missense_Mutation_p.D212N	NM_012308.2	NP_036440.1	Q9Y2K7	KDM2A_HUMAN	lysine (K)-specific demethylase 2A	754		NA		NA	regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleoplasm	DNA binding|histone demethylase activity (H3-K36 specific)|oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen|protein binding|zinc ion binding			NS(1)|breast(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(6)|lung(15)|ovary(5)|skin(1)|urinary_tract(2)	36						TGCCAGCCGCGATGAGCGCTT	0.632		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0													29	34	33	NA		NA	NA	11		NA											NA				67017761		1971	4143	6114	SO:0001583	missense			ENSG00000173120	HGNC:13606	NM_012308	Approved	uc001ojw.3	NA	Q49A21|Q4G0M3|Q69YY8|Q9BVH5|Q9H7H5|Q9UK66	ENST00000529006.2	37	CCDS44657.1	.	.	.	.	.	.	.	.	.	.	G	25.0	4.596216	0.86953	.	.	ENSG00000173120	ENST00000398645;ENST00000529006;ENST00000530342;ENST00000446134;ENST00000308783	T;T;T;T	0.50813	0.73;0.96;0.96;0.96	6.02	6.02	0.97574	.	0.261162	0.44902	D	0.000409	T	0.41903	0.1179	L	0.50333	1.59	0.58432	D	0.999999	P;P	0.35011	0.48;0.48	B;B	0.21360	0.034;0.034	T	0.28299	-1.0048	10	0.38643	T	0.18	-16.4146	18.7178	0.91682	0.0:0.0:1.0:0.0	.	212;754	D4QA03;Q9Y2K7	.;KDM2A_HUMAN	N	754;754;315;315;212	ENSP00000381640:D754N;ENSP00000432786:D754N;ENSP00000435776:D315N;ENSP00000309302:D212N	ENSP00000309302:D212N	D	+	1	0	KDM2A	66774337	1.000000	0.71417	0.987000	0.45799	0.991000	0.79684	5.807000	0.69157	2.857000	0.98124	0.650000	0.86243	GAT	KDM2A-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000393140.2	63.363476	KEEP	NA	+	64.130775	0.375	21	35	---	---	---	---	1	0.9999927	43	40	2	68	24	39	2	68	8	TP
C2CD3	26005	broad.mit.edu	37	11	73806316	73806316	+	Silent	SNP	G	G	A			THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	g.chr11:73806316G>A	ENST00000334126.7	-	17	3343	c.3117C>T	c.(3115-3117)caC>caT	p.H1039H	C2CD3_ENST00000313663.7_Silent_p.H1039H			Q4AC94	C2CD3_HUMAN	C2 calcium-dependent domain containing 3	1039		NA		NA		centrosome				NS(1)|breast(1)|cervix(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(16)|lung(26)|ovary(4)|pancreas(2)|prostate(1)|skin(3)	64	Breast(11;4.16e-06)					TGGATTGAGAGTGTTGAACTG	0.393		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0													172	164	166	NA		NA	NA	11		NA											NA				73806316		2200	4293	6493	SO:0001819	synonymous_variant			ENSG00000168014	HGNC:24564	NM_015531	Approved	uc001ouu.2	NA	C9JR55|E2QRD1|Q2NLE1|Q3C1U9|Q6ZU92|Q8IYM4|Q8NB87|Q8NDH7|Q9Y4M2	ENST00000334126.7	37																																																																																				C2CD3-201	KNOWN	basic	protein_coding	NA	protein_coding		90.986783	KEEP	NA	-	93.464611	0.329897	32	65	---	---	---	---	1	0.9481914	5	8	0	154	33	69	0	154	2	TP
AKT1	207	broad.mit.edu	37	14	105246551	105246551	+	Missense_Mutation	SNP	C	C	T	rs34409589|rs121434592		THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	g.chr14:105246551C>T	ENST00000554581.1	-	2	1529	c.49G>A	c.(49-51)Gag>Aag	p.E17K	AKT1_ENST00000555528.1_Missense_Mutation_p.E17K|AKT1_ENST00000554848.1_Missense_Mutation_p.E17K|AKT1_ENST00000544168.1_5'Flank|AKT1_ENST00000407796.2_Missense_Mutation_p.E17K|AKT1_ENST00000402615.2_Missense_Mutation_p.E17K|AKT1_ENST00000349310.3_Missense_Mutation_p.E17K			P31749	AKT1_HUMAN	v-akt murine thymoma viral oncogene homolog 1	17	PH.	NA	E -> K (in breast cancer; also detected in colorectal and ovarian cancer; somatic mutation; alters the PH domain conformation; results in activation of the protein; alters the subcellular location of the protein to the plasma membrane).	NA	activation of pro-apoptotic gene products|activation-induced cell death of T cells|endocrine pancreas development|G-protein coupled receptor protein signaling pathway|glucose metabolic process|glycogen biosynthetic process|induction of apoptosis by intracellular signals|insulin receptor signaling pathway|insulin-like growth factor receptor signaling pathway|mRNA metabolic process|negative regulation of fatty acid beta-oxidation|negative regulation of plasma membrane long-chain fatty acid transport|negative regulation of protein kinase activity|nerve growth factor receptor signaling pathway|nitric oxide biosynthetic process|peptidyl-serine phosphorylation|phosphatidylinositol-mediated signaling|platelet activation|positive regulation of blood vessel endothelial cell migration|positive regulation of cell growth|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of establishment of protein localization in plasma membrane|positive regulation of fat cell differentiation|positive regulation of glucose import|positive regulation of glycogen biosynthetic process|positive regulation of lipid biosynthetic process|positive regulation of nitric oxide biosynthetic process|positive regulation of nitric-oxide synthase activity|positive regulation of peptidyl-serine phosphorylation|positive regulation of sequence-specific DNA binding transcription factor activity|protein autophosphorylation|protein import into nucleus, translocation|regulation of neuron projection development|regulation of translation|response to fluid shear stress|response to heat|response to UV-A|T cell costimulation	cytosol|nucleoplasm|plasma membrane	enzyme binding|identical protein binding|nitric-oxide synthase regulator activity|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,4-bisphosphate binding|protein serine/threonine kinase activity	p.E17K(102)		NS(3)|breast(97)|central_nervous_system(2)|endometrium(13)|haematopoietic_and_lymphoid_tissue(4)|kidney(1)|large_intestine(7)|lung(10)|ovary(2)|pancreas(1)|prostate(6)|skin(5)|thyroid(10)|urinary_tract(15)	176		all_cancers(154;3.77e-06)|all_lung(585;3.24e-07)|all_epithelial(191;3.45e-05)|all_neural(303;0.0459)|Melanoma(154;0.155)	all cancers(16;0.000486)|OV - Ovarian serous cystadenocarcinoma(23;0.00647)|Epithelial(46;0.0153)|GBM - Glioblastoma multiforme(11;0.116)	all cancers(159;0.0107)|OV - Ovarian serous cystadenocarcinoma(161;0.0132)|Epithelial(152;0.243)	Adenosine triphosphate(DB00171)|Arsenic trioxide(DB01169)	TTGATGTACTCCCCTACAGAC	0.612	E17K(KU1919_URINARY_TRACT)	1	Mis		"""breast, colorectal, ovarian, NSCLC"""	NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA	Dom	yes	NA	14	14q32.32	207	v-akt murine thymoma viral oncogene homolog 1		E	102	Substitution - Missense(102)	breast(49)|urinary_tract(14)|thyroid(10)|endometrium(10)|lung(7)|large_intestine(4)|prostate(4)|central_nervous_system(1)|haematopoietic_and_lymphoid_tissue(1)|ovary(1)|NS(1)											130	93	106	NA		NA	NA	14		NA											NA				105246551		2203	4300	6503	SO:0001583	missense				HGNC:391	NM_005163	Approved	uc001ypn.3	NA	B2RAM5|Q9BWB6	ENST00000554581.1	37	CCDS9994.1	.	.	.	.	.	.	.	.	.	.	C	23.8	4.458989	0.84317	.	.	ENSG00000142208	ENST00000554581;ENST00000407796;ENST00000349310;ENST00000402615;ENST00000555528;ENST00000554848;ENST00000555926	T;T;T;T;T;T;T	0.37915	1.17;1.17;1.17;1.17;1.17;1.17;1.17	4.61	4.61	0.57282	Pleckstrin homology-type (1);Pleckstrin homology domain (3);	0.000000	0.85682	D	0.000000	T	0.59838	0.2223	M	0.71581	2.175	0.80722	D	1	D	0.89917	1.0	D	0.97110	1.0	T	0.64411	-0.6414	10	0.72032	D	0.01	.	16.1757	0.81847	0.0:1.0:0.0:0.0	.	17	P31749	AKT1_HUMAN	K	17	ENSP00000451828:E17K;ENSP00000384293:E17K;ENSP00000270202:E17K;ENSP00000385326:E17K;ENSP00000450688:E17K;ENSP00000451166:E17K;ENSP00000451824:E17K	ENSP00000270202:E17K	E	-	1	0	AKT1	104317596	1.000000	0.71417	0.639000	0.29394	0.296000	0.27459	7.347000	0.79356	2.395000	0.81488	0.462000	0.41574	GAG	AKT1-005	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000410418.1	31.91448	KEEP	NA	-	32.72606	0.333333	11	22	---	---	---	---	1	1	65	112	0	54	13	28	0	54	2	TP
LINGO1	84894	broad.mit.edu	37	15	77906580	77906580	+	Missense_Mutation	SNP	G	G	C			THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna	NA	NA	Illumina GAIIx	THCA-TCGA-FY-A4B4-Tumor-SM-3O9QY	THCA-TCGA-FY-A4B4-Normal-SM-3O9R3	g.chr15:77906580G>C	ENST00000355300.6	-	2	1843	c.1669C>G	c.(1669-1671)Ctc>Gtc	p.L557V	LINGO1_ENST00000561030.1_Missense_Mutation_p.L551V	NM_032808.5	NP_116197.4	Q96FE5	LIGO1_HUMAN	leucine rich repeat and Ig domain containing 1	557		NA		NA	negative regulation of axonogenesis|nerve growth factor receptor signaling pathway	integral to membrane|plasma membrane				breast(1)|central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(7)|lung(16)|ovary(1)|prostate(1)|upper_aerodigestive_tract(1)	31						GCGATGATGAGGGTCTTGATG	0.597		NA				NA		NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA				0													127	134	131	NA		NA	NA	15		NA											NA				77906580		2165	4269	6434	SO:0001583	missense				HGNC:21205	NM_032808	Approved	uc002bct.1	NA	D3DW80|Q6NUK3|Q6UXM3|Q6VVG0|Q6VVG1|Q6VVG2|Q8N3K5|Q96K52	ENST00000355300.6	37	CCDS45313.1	.	.	.	.	.	.	.	.	.	.	G	8.625	0.892315	0.17613	.	.	ENSG00000169783	ENST00000355300	T	0.53423	0.62	5.36	5.36	0.76844	.	0.000000	0.85682	D	0.000000	T	0.44180	0.1281	M	0.65498	2.005	0.58432	D	0.999997	B	0.31009	0.303	B	0.32393	0.145	T	0.29212	-1.0019	10	0.11182	T	0.66	.	12.4377	0.55608	0.0767:0.0:0.9233:0.0	.	557	Q96FE5	LIGO1_HUMAN	V	557	ENSP00000347451:L557V	ENSP00000347451:L557V	L	-	1	0	LINGO1	75693635	1.000000	0.71417	1.000000	0.80357	0.989000	0.77384	4.012000	0.57131	2.509000	0.84616	0.561000	0.74099	CTC	LINGO1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000419546.1	84.126941	KEEP	NA	-	85.038829	0.384615	30	48	---	---	---	---	1	0.8108382	4	3	0	102	31	50	0	102	2	TP
